ID   ADA1A_RAT               Reviewed;         466 AA.
AC   P43140;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   29-MAY-2024, entry version 181.
DE   RecName: Full=Alpha-1A adrenergic receptor;
DE   AltName: Full=Alpha-1A adrenoreceptor;
DE            Short=Alpha-1A adrenoceptor;
DE   AltName: Full=Alpha-1C adrenergic receptor;
GN   Name=Adra1a; Synonyms=Adra1c;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Heart muscle;
RX   PubMed=7923624; DOI=10.1161/01.res.75.4.796;
RA   Stewart A.F., Rokosh D.G., Bailey B.A., Karns L.R., Chang K.C., Long C.S.,
RA   Kariya K., Simpson P.C.;
RT   "Cloning of the rat alpha 1C-adrenergic receptor from cardiac myocytes.
RT   Alpha 1C, alpha 1B, and alpha 1D mRNAs are present in cardiac myocytes but
RT   not in cardiac fibroblasts.";
RL   Circ. Res. 75:796-802(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=7935320;
RA   Laz T.M., Forray C., Smith K.E., Bard J.A., Vaysse P.J., Branchek T.A.,
RA   Weinshank R.L.;
RT   "The rat homologue of the bovine alpha 1c-adrenergic receptor shows the
RT   pharmacological properties of the classical alpha 1A subtype.";
RL   Mol. Pharmacol. 46:414-422(1994).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=8185565; DOI=10.1006/bbrc.1994.1575;
RA   Rokosh D.G., Bailey B.A., Stewart A.F., Karns L.R., Long C.S.,
RA   Simpson P.C.;
RT   "Distribution of alpha 1C-adrenergic receptor mRNA in adult rat tissues by
RT   RNase protection assay and comparison with alpha 1B and alpha 1D.";
RL   Biochem. Biophys. Res. Commun. 200:1177-1184(1994).
CC   -!- FUNCTION: This alpha-adrenergic receptor mediates its action by
CC       association with G proteins that activate a phosphatidylinositol-
CC       calcium second messenger system. Its effect is mediated by G(q) and
CC       G(11) proteins. Nuclear ADRA1A-ADRA1B heterooligomers regulate
CC       phenylephrine (PE)-stimulated ERK signaling in cardiac myocytes (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homo- and heterooligomer. Heterooligomerizes with ADRA1B
CC       homooligomers in cardiac myocytes. Interacts with CAVIN4.
CC       {ECO:0000250|UniProtKB:P35348}.
CC   -!- SUBCELLULAR LOCATION: Nucleus membrane; Multi-pass membrane protein.
CC       Cell membrane {ECO:0000250|UniProtKB:P35348}; Multi-pass membrane
CC       protein {ECO:0000255}. Cytoplasm {ECO:0000250|UniProtKB:P35348}.
CC       Membrane, caveola {ECO:0000250|UniProtKB:P35348}. Note=Location at the
CC       nuclear membrane facilitates heterooligomerization and regulates ERK-
CC       mediated signaling in cardiac myocytes. Colocalizes with GNAQ, PLCB1 as
CC       well as LAP2 at the nuclear membrane of cardiac myocytes (By
CC       similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Abundant in heart, brain, aorta, vena cava, vas
CC       deferens, submaxillary gland, lung, and kidney. Found at lower levels
CC       in prostate, parotid gland and skeletal muscle.
CC       {ECO:0000269|PubMed:8185565}.
CC   -!- PTM: C-terminal Ser or Thr residues may be phosphorylated.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       Adrenergic receptor subfamily. ADRA1A sub-subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U13368; AAA52103.1; -; mRNA.
DR   EMBL; U07126; AAA62866.1; -; mRNA.
DR   PIR; I57959; I57959.
DR   RefSeq; NP_058887.2; NM_017191.2.
DR   RefSeq; XP_006252169.1; XM_006252107.3.
DR   RefSeq; XP_008768966.1; XM_008770744.2.
DR   AlphaFoldDB; P43140; -.
DR   SMR; P43140; -.
DR   IntAct; P43140; 1.
DR   STRING; 10116.ENSRNOP00000012736; -.
DR   BindingDB; P43140; -.
DR   ChEMBL; CHEMBL319; -.
DR   DrugCentral; P43140; -.
DR   GuidetoPHARMACOLOGY; 22; -.
DR   GlyCosmos; P43140; 3 sites, No reported glycans.
DR   GlyGen; P43140; 3 sites.
DR   PhosphoSitePlus; P43140; -.
DR   PaxDb; 10116-ENSRNOP00000012736; -.
DR   GeneID; 29412; -.
DR   KEGG; rno:29412; -.
DR   UCSC; RGD:2055; rat.
DR   AGR; RGD:2055; -.
DR   CTD; 148; -.
DR   RGD; 2055; Adra1a.
DR   VEuPathDB; HostDB:ENSRNOG00000009522; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   HOGENOM; CLU_009579_11_6_1; -.
DR   InParanoid; P43140; -.
DR   OrthoDB; 4073525at2759; -.
DR   PhylomeDB; P43140; -.
DR   TreeFam; TF331895; -.
DR   Reactome; R-RNO-390696; Adrenoceptors.
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   Reactome; R-RNO-416482; G alpha (12/13) signalling events.
DR   PRO; PR:P43140; -.
DR   Proteomes; UP000002494; Chromosome 15.
DR   Bgee; ENSRNOG00000009522; Expressed in heart and 10 other cell types or tissues.
DR   GO; GO:0005901; C:caveola; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0098691; C:dopaminergic synapse; IDA:SynGO.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0031965; C:nuclear membrane; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0030315; C:T-tubule; IDA:RGD.
DR   GO; GO:0030018; C:Z disc; IDA:RGD.
DR   GO; GO:0004937; F:alpha1-adrenergic receptor activity; IDA:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0071880; P:adenylate cyclase-activating adrenergic receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007512; P:adult heart development; ISO:RGD.
DR   GO; GO:0060402; P:calcium ion transport into cytosol; IMP:BHF-UCL.
DR   GO; GO:0061049; P:cell growth involved in cardiac muscle cell development; ISO:RGD.
DR   GO; GO:0007267; P:cell-cell signaling; IBA:GO_Central.
DR   GO; GO:0000165; P:MAPK cascade; ISO:RGD.
DR   GO; GO:0010507; P:negative regulation of autophagy; ISO:RGD.
DR   GO; GO:0001985; P:negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure; ISO:RGD.
DR   GO; GO:0035024; P:negative regulation of Rho protein signal transduction; IMP:MGI.
DR   GO; GO:0150099; P:neuron-glial cell signaling; ISO:RGD.
DR   GO; GO:0001994; P:norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure; ISO:RGD.
DR   GO; GO:0035265; P:organ growth; ISO:RGD.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0097195; P:pilomotor reflex; ISO:RGD.
DR   GO; GO:0045760; P:positive regulation of action potential; IMP:RGD.
DR   GO; GO:0060452; P:positive regulation of cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0010613; P:positive regulation of cardiac muscle hypertrophy; ISO:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IMP:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:BHF-UCL.
DR   GO; GO:0010460; P:positive regulation of heart rate; IMP:RGD.
DR   GO; GO:0001996; P:positive regulation of heart rate by epinephrine-norepinephrine; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0090037; P:positive regulation of protein kinase C signaling; IDA:RGD.
DR   GO; GO:0045987; P:positive regulation of smooth muscle contraction; IMP:RGD.
DR   GO; GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IDA:RGD.
DR   GO; GO:0003084; P:positive regulation of systemic arterial blood pressure; IMP:RGD.
DR   GO; GO:0001997; P:positive regulation of the force of heart contraction by epinephrine-norepinephrine; ISO:RGD.
DR   GO; GO:0045907; P:positive regulation of vasoconstriction; IDA:RGD.
DR   GO; GO:0099171; P:presynaptic modulation of chemical synaptic transmission; IDA:SynGO.
DR   GO; GO:0008217; P:regulation of blood pressure; ISO:RGD.
DR   GO; GO:0009725; P:response to hormone; IMP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IMP:RGD.
DR   CDD; cd15325; 7tmA_alpha1A_AR; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR002233; ADR_fam.
DR   InterPro; IPR001004; ADRA1A_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR24248; ADRENERGIC RECEPTOR-RELATED G-PROTEIN COUPLED RECEPTOR; 1.
DR   PANTHER; PTHR24248:SF16; ALPHA-1A ADRENERGIC RECEPTOR; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR01103; ADRENERGICR.
DR   PRINTS; PR00557; ADRENRGCA1AR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Cytoplasm; Disulfide bond; G-protein coupled receptor;
KW   Glycoprotein; Lipoprotein; Membrane; Nucleus; Palmitate; Phosphoprotein;
KW   Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..466
FT                   /note="Alpha-1A adrenergic receptor"
FT                   /id="PRO_0000069066"
FT   TOPO_DOM        1..27
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        28..51
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        52..64
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        65..88
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        89..99
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        100..122
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        123..143
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        144..167
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        168..181
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        182..205
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        206..273
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        274..297
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        298..305
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        306..329
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        330..466
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   MOTIF           334..349
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         215
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000255"
FT   LIPID           345
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        7
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        13
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        22
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        99..176
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   CONFLICT        39
FT                   /note="F -> L (in Ref. 1; AAA52103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        67
FT                   /note="N -> G (in Ref. 1; AAA52103)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   466 AA;  51598 MW;  4962D3A72E971A36 CRC64;
     MVLLSENASE GSNCTHPPAP VNISKAILLG VILGGLIIFG VLGNILVILS VACHRHLHSV
     THYYIVNLAV ADLLLTSTVL PFSAIFEILG YWAFGRVFCN IWAAVDVLCC TASIMGLCII
     SIDRYIGVSY PLRYPTIVTQ RRGVRALLCV WVLSLVISIG PLFGWRQPAP EDETICQINE
     EPGYVLFSAL GSFYVPLAII LVMYCRVYVV AKRESRGLKS GLKTDKSDSE QVTLRIHRKN
     VPAEGGGVSS AKNKTHFSVR LLKFSREKKA AKTLGIVVGC FVLCWLPFFL VMPIGSFFPD
     FKPSETVFKI VFWLGYLNSC INPIIYPCSS QEFKKAFQNV LRIQCLRRRQ SSKHALGYTL
     HPPSQALEGQ HRDMVRIPVG SGETFYKISK TDGVCEWKFF SSMPQGSARI TVPKDQSACT
     TARVRSKSFL QVCCCVGSSA PRPEENHQVP TIKIHTISLG ENGEEV
//
